Balas NM, Perichart PO, Pantoja AL, Rodríguez CA, Ortiz LG

Language: Spanish
References: 44
Page: 515-526
PDF size: 193.69 Kb.

ABSTRACT

Background: The posmenopausal women has higher cardiovascular risks, since their concentrations of glucose, insulin, total cholesterol, LDL cholesterol, triacilglycerides and lipoproteins are bigger, while their HDL-cholesterol decreases; this factors increases the risk of suffering metabolic syndrome.
Objective: To describe the nutritional status and cardiovascular risk of Mexican posmenopausal women with metabolic syndrome.
Methods: In a cross-sectional study, we assessed the nutritional status and cardiovascular risk factors of Mexican women (n = 93) with overweight or obesity and metabolic syndrome.
Results: The three most frequent met criteria for metabolic syndrome were abdominal obesity, hypertriglyceridemia and low HDL-cholesterol levels. Without considering abdominal obesity, the most common alterations during initial assessment were high LDL cholesterol levels, low HDL cholesterol levels and hypertriglyceridemia. Women with a body mass index up to 35 did not appear to have higher values than overweight and obese grade I women. We did not find differences in metabolic variables among older women or in those using hormone therapy. A high carbohydrate and saturated fat intake was observed, as well as high fat dairy and frequent non healthy cooking methods. On the other hand, intake of fruits, vegetables, and high fiber carbohydrates was low. Average physical activity was reported to be only 30 minutes a week.
Conclusions: The observed dietary pattern in these women, and their inactivity level could be exacerbating their cardiovascular risk factors. The promotion of a cardioprotective dietary pattern in these women is essential and urgent.

REFERENCES

1. Maturana MA, Irigoyen MC, Spritzer PM. Menopause, estrogens and endotelial dysfunction: current concepts. Clinics 2007; 62(1):77-86.

2. Ortega CP, Morán C, Blanco MJ, Yunes DE, et al. Factores reproductivos y de estilo de vida relacionados con menopausia temprana en mujeres mexicanas. Salud Publica Mex 2006;48:300-7.

3. Carr M. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metabol 2003;88:2404-11.

4. Chedraui P, Hidalgo L, Chavez D, Morocho N, et al. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gynecol Obstet 2007;275:161-8.

5. Zárate A, Basurto L, Hernández M. El síndrome metabólico de la mujer posmenopáusica. Implicaciones clínicas. Gac Med Mex 2003;139(6):625-8.

6. Instituto Nacional de Estadística, Geografía e Informática. Estadísticas de mortalidad. Porcentajes de defunciones generales de 30 a 64 años por sexo y principales causas: 1990 a 2005 (2006). www.inegi/gob/mx

7. Consenso Mexicano sobre el Tratamiento Integral del Síndrome Metabólico. Rev Med Cardiol 2002;13(1):4-30.

8. National Institutes of Health. National Heart, Lung, and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. NIH Publication No. 01-3670. USA 2001.

9. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetes Med 1998;15:539-53.

10. International Diabetes Federation. Worldwide definition of the metabolic syndrome (2007). http://www.idf.org/webdata/docs/IDF_metabolic syndrome_definition.PDF.

11. Aguilar SC, Rojas R, Gómez F, Franco A, Olaiz G, Rull A, Sepúlveda J. El síndrome metabólico: un concepto en evolución. Gac Med Mex 2004;140:41-48.

12. Odgerel T, Han J, Yang C, Mao J. The relationship between sex hormones and the extent of coronary artery disease in postmenopausal women. Chin Med J 2007;120(1):71-73.

13. Olaiz FG, Rivera DJ, Shamah LT, Rojas R, editores. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.

14. Grundy S, Cleeman J, Daniels S, Donato K, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-52.

15. Adult Weight Management Nutrition Practice Guidelines. American Dietetic Association Evidence Analysis Library, 2006.

16. Hu F, Willett W. Optimal diets for prevention of coronary heart disease. JAMA 2002;288:2569-78.

17. Fung T, Willett W, Stampfer M, Manson J, Hu F. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med 2001;161:1857-62.

18. Hu F, Stampfer M, Manson J, Rimm E, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-9.

19. Howard BV, Van Horn L, Hsia J, Manson JE, et al. Low fat dietary pattern and risk of cardiovascular disease: The Women’s Health Initiative randomized controlled dietary modification trial. JAMA 2006;295(6):655-66.

20. Appel L, Moore T, Obarzanek E, Vollmer W, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-24.

21. U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary guidelines for americans, 2005. 6th Ed. Government Printing Office: Washington, 2005.

22. Lorgeril M, Salen P, Jean-Louis M, Monjaud I, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infraction. Final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.

23. Mosca L, Appel L, Benjamin E, Berra K, et al. AHA guidelines. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004;109:672-93.

24. American Dietetic Association. Disorders of lipid metabolism evidence analysis project. Evidence Analysis Library, 2005.

25. Espino S. Estudio piloto en la transición menopáusica del síndrome metabólico y las modificaciones en el metabolismo de los lípidos con la terapia de reemplazo hormonal (tesis). Instituto Nacional de Perinatología 2003;p:57.

26. WHO Expert Committee. Physical status: the use and interpretation of anthropometry. Technical report series. Geneva 1995;pp:854.

27. Lohman T. Advances in body composition assessment. Champaign, IL: Human Kinetics Publishers, 1992.

28. National Institutes of Health. National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. USA, 1998.

29. Pickering T, Hall J, Appel L, Falkner B, et al. Recommendations for blood pressure measurements in humans and experimental animals. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45:142-61.

30. Fieldwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.

31. Conway J, Ingwersen L, Vinyard B, Moshfegh A. Effectiveness of the US Department of Agriculture 5-step multiple pass method in assessing food intake in obese and nonobese women. Am J Clin Nutr 2003;77:1171-8.

32. Chávez M, Hernández M, Roldán J. Tablas de uso práctico del valor nutritivo de los alimentos de mayor consumo en México. Comisión Nacional de Alimentación. Instituto Nacional de la Nutrición Salvador Zubirán, 1992.

33. Institute of Medicine. Dietary reference intakes: energy, carbohydrate,fiber, fat, fatty acids, cholesterol, protein and amino acids. A report of the panel on micronutrients, subcommittees on upper reference levels of nutrients and interpretation and uses of dietary reference intakes. Standing committee on the scientific evaluation of dietary reference intakes. Washington, DC: The National Academies Press, 2005.

34. Zhu S, Heymsfield S, Toyoshima H, Wang Z, et al. Race-ethnicity- specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr 2005;81:409-15.

35. Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, et al. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22(8):447-54.

36. Oliveira A, Mancini J. Perfil nutricional e lipemico de mulheres na pos-menopausa com doenca arterial coronaria. Arquivos Brasileiros de Cardiologia 2005;84(4):325-29.

37. Pines A, Bornstein NM, Shapira I. Menopause and ischaemic stroke: basic, clinical and epidemiological considerations. The role of hormone replacement. Hum Reprod Update 2002;8(2):161-8.

38. Larson DE, Hunter GR, Williams MJ, Kekes-Szabo T, et al. Dietary fat in relation to body fat and intraabdominal adipose tissue: a cross sectional analysis. Am J Clin Nutr 1996;64:677-84.

39. Doucet E, Almeras N, White M, Despres JP, et al. Dietary fat composition and human adiposity. European J Clin Nutr 1998;52:2-6.

40. North American Menopause Society. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 2006;13(6):862-77.

41. McCauley K. Modifying women’s risk for cardiovascular disease. J Obstet Gynecol Neonatal Nurs 2007;36(2):116-24.

42. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med 2002;346(6):393-403.

43. Kuller L, Simkin-Silverman L, Wing R, Meilahn E, Ines D. Women’s healthy lifestyle project: a randomized clinical trial results of 54 months. Circulation 2005;108:32-37.

44. Toobert DJ, Glasgow RE, Strycker LA, Barrera M, et al. Biological and quality of life outcomes from the Mediterranean lifestyle program: a randomized control trial. Diabetes Care 2002;26(8):2288-93.